Anti-ERBB2 (trastuzumab)-AcLys-VC-PABC-MMAD ADC

• Description:

  This ADC product is comprised of an engineerd anti-ERBB2 antibody (trastuzumab with LLQGG tag at Fc) conjugated via a AcLys-VC-PABC linker to MMAD. The MMAD is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAD binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.

• Format:

  Solution

• Shipping Conditions:

  Ice Packs

• Storage Conditions:

  -20°C

• CAS Number:

  9007-83-4